Infusing arginine vasopressin (AVP) in vasodilatory shock usually decreases cardiac output and thus systemic oxygen transport. It is still a matter of debate whether this vasoconstriction impedes visceral organ blood flow and thereby causes organ dysfunction and injury. Therefore, we tested the hypothesis whether low-dose AVP is safe with respect to liver, kidney, and heart function and organ injury during resuscitated septic shock
Current therapy of septic/vasodilatory cardiovascular failure includes volume resuscitation and infu...
Objective: To compare the effects of a first-line therapy of combined arginine vasopressin, levosime...
PURPOSE OF REVIEW: To describe the effects of arginine vasopressin other than its vasoconstrictive a...
International audienceInfusing arginine vasopressin (AVP) in vasodilatory shock usually decreases ca...
INTRODUCTION: Infusing arginine vasopressin (AVP) in vasodilatory shock usually decreases cardiac ou...
INTRODUCTION: Vasopressin has been shown to increase blood pressure in catecholamine-resistant septi...
To access publisher full text version of this article. Please click on the hyperlink in Additional L...
In patients with hyperdynamic hemodynamics, infusing arginine vasopressin (AVP) in advanced vasodila...
Purpose: To compare the effects of two arginine vasopressin (AVP) dose regimens on the hemodynamic r...
To access publisher full text version of this article. Please click on the hyperlink in Additional L...
INTRODUCTION: The objective of this study was to evaluate the effects of two different mean arterial...
OBJECTIVE: The use of vasopressors for treatment of hypotension in sepsis may have adverse effects o...
Given the controversial experimental and clinical data reported in the literature, up to now it is r...
To access publisher full text version of this article. Please click on the hyperlink in Additional L...
During advanced vasodilatory shock, arginine vasopressin (AVP) is increasingly used to restore blood...
Current therapy of septic/vasodilatory cardiovascular failure includes volume resuscitation and infu...
Objective: To compare the effects of a first-line therapy of combined arginine vasopressin, levosime...
PURPOSE OF REVIEW: To describe the effects of arginine vasopressin other than its vasoconstrictive a...
International audienceInfusing arginine vasopressin (AVP) in vasodilatory shock usually decreases ca...
INTRODUCTION: Infusing arginine vasopressin (AVP) in vasodilatory shock usually decreases cardiac ou...
INTRODUCTION: Vasopressin has been shown to increase blood pressure in catecholamine-resistant septi...
To access publisher full text version of this article. Please click on the hyperlink in Additional L...
In patients with hyperdynamic hemodynamics, infusing arginine vasopressin (AVP) in advanced vasodila...
Purpose: To compare the effects of two arginine vasopressin (AVP) dose regimens on the hemodynamic r...
To access publisher full text version of this article. Please click on the hyperlink in Additional L...
INTRODUCTION: The objective of this study was to evaluate the effects of two different mean arterial...
OBJECTIVE: The use of vasopressors for treatment of hypotension in sepsis may have adverse effects o...
Given the controversial experimental and clinical data reported in the literature, up to now it is r...
To access publisher full text version of this article. Please click on the hyperlink in Additional L...
During advanced vasodilatory shock, arginine vasopressin (AVP) is increasingly used to restore blood...
Current therapy of septic/vasodilatory cardiovascular failure includes volume resuscitation and infu...
Objective: To compare the effects of a first-line therapy of combined arginine vasopressin, levosime...
PURPOSE OF REVIEW: To describe the effects of arginine vasopressin other than its vasoconstrictive a...